Creative BioMart Updated Its Protein Engineering Rational Design Services

Profacgen Announces New Fermentation Process Development Solutions

Biopharma PEG Provides PEG Derivatives Used As PROTAC Linker

Huateng Pharma Supplies SGLT-2 inhibitors Against Type 2 Diabetes

ChargePoint Technology Acquires PuroVaso

SHORTLIST ANNOUNCED FOR INAUGURAL SUSTAINABLE MEDICINES PACKAGING AWARDS

MicrobioSeq Boosts Microbial Community Research with Long-Read Metagenomic Sequencing

CD Genomics RNA-Solutions Platform Announces the Launch of Nanopore Direct RNA Sequencing

physIQ Announces Collaboration with InCarda Therapeutics and Syneos Health to Accelerate Innovative Phase III Study in Patients with Atrial Fibrillation

A leader in continuous remote patient monitoring and data analytics, physIQ today announced a strategic collaboration with InCarda Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases. Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, recommended physIQ’s innovative monitoring solution to help advance InCarda’s clinical study of InRhythm™ (orally inhaled flecainide) in patients with atrial fibrillation (AF) – one of the most common heart arrhythmias that affects one in four adults over the age of 40.1

Thermo Fisher Scientific Expands Viral Vector Manufacturing Capabilities

Lonza Strengthens Micronization Portfolio with the Introduction of X-Ray Powder Diffraction Capability in Monteggio (CH)

Athenex Partners with Leading Contract Manufacturer GenScript ProBio in the Development of Advanced Cell and Gene Therapies

GenScript ProBio announced that it has expanded its partnership with Athenex which is a leading biopharmaceutical business that is committed to the development, discovery and commercialization of innovative therapies to treat cancer and related disorders as well as the creation of cutting-edge treatments for gene and cell therapy with the benefit of a preferred collaboration.

Cellefill™, a new integrated solution to fast-track cell, gene and biological therapies

Curebase Names Medical Research Veteran Sean Lynch as VP of Clinical Operations

Curebase, a company committed to democratizing access to clinical studies, has named veteran clinical research executive Sean Lynch as vice president of clinical operations.

MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities Top connectivity services company will leverage Lyniate EMPI solution to strengthen the accuracy of the data it exchanges to better serve its clients and partners

Nanopowder Compounds Unleash Potentials for Nano-Sensors, Nano-Semiconductors, Nano-Ceramics and Nano-Catalysts

SpIntellx and iCura Diagnostics Partner to Expand Access to Advanced Spatial Analytics and Explainable AI Products for Pathology and Oncology Research

SpIntellx, Inc., a leader in spatially intelligent biology, and iCura Diagnostics, a leading contract research organization (CRO) focused on capitalizing multiomic data to accelerate end-to-end clinical workflow solutions and biomarker discovery, today announced a partnership to transform precision oncology through unlocking the power of genomic, proteomics, and transcriptomic data using advanced spatial analytics.

What is the precision medicine?

Precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person."

Inizio strengthens leadership team with two key appointments

BioAgilytix announces appointment of Dr. Linda Robbie as Chief Operating Officer

BioAgilytix Labs, LLC (BioAgilytix), a leading contract research organization supporting pharmaceutical and biotech partners in all phases of drug development, has announced the appointment of Dr. Linda Robbie as Chief Operating Officer. This appointment was effective as of August 9th, 2022.